- Report
- November 2024
- 175 Pages
Global
From €4671EUR$5,000USD£3,952GBP
- Report
- October 2024
- 195 Pages
Global
From €3312EUR$3,545USD£2,802GBP
€3680EUR$3,939USD£3,113GBP
- Report
- March 2025
- 175 Pages
Global
From €4195EUR$4,490USD£3,549GBP
- Report
- February 2025
- 200 Pages
Global
From €4195EUR$4,490USD£3,549GBP
- Report
- May 2024
- 137 Pages
Global
From €6071EUR$6,499USD£5,136GBP
- Report
- May 2024
- 138 Pages
Global
From €6071EUR$6,499USD£5,136GBP
- Report
- November 2018
- 30 Pages
China
From €2055EUR$2,200USD£1,739GBP
- Report
- March 2024
- 159 Pages
Global
From €7427EUR$7,950USD£6,283GBP
- Report
- February 2024
- 91 Pages
Global
From €3500EUR$4,013USD£3,065GBP
- Report
- April 2025
- 50 Pages
Global
From €2476EUR$2,650USD£2,094GBP
Bisoprolol is a drug used to treat cardiovascular diseases, such as hypertension, angina, and heart failure. It is a beta-blocker, meaning it works by blocking the action of certain hormones in the body, such as adrenaline, which can cause the heart to beat faster and blood vessels to narrow. Bisoprolol is usually taken once a day, either with or without food. Common side effects include dizziness, fatigue, and nausea.
Bisoprolol is available in both generic and brand-name forms. It is typically prescribed as a first-line treatment for hypertension, and is often used in combination with other drugs to treat more severe cases. It is also used to treat angina and heart failure, and is sometimes prescribed to reduce the risk of stroke or heart attack.
The Bisoprolol market is highly competitive, with many companies offering generic and brand-name versions of the drug. Some of the major players in the market include Pfizer, Novartis, Merck, Sanofi, and GlaxoSmithKline. Show Less Read more